FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156776836> ?p ?o ?g. }

• W3156776836 endingPage "26" @default.
• W3156776836 startingPage "14" @default.
• W3156776836 abstract "Down syndrome (DS) is one of the most common chromosomal abnormalities. Children with DS are more likely to develop acute lymphoblastic leukemia (ALL). Standard therapy is usually used to treat DS-ALL, but children with DS-ALL have an inferior outcome compared to non-DS patients, mainly due to increased therapy toxicity. The purpose of the study: in this study we aimed to analyze our experience of treating DS-ALL according to original protocol “Moscow–Berlin”. This study is supported by the Independent Ethics Committee and approved by the Academic Council of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology. The analysis included primary ALL patients, aged 1 to 18 years, who received therapy in Russian and Belarusian clinics participating in the “Moscow–Berlin” study from January 2008 to December 2020. To analyze the treatment results of SD-ALL patients, a comparison group was formed from all patients with ALL registered in the database, using the matched-pair method. A total of 8296 ALL patients were registered in the database, of which 135 (1.63%) were patients with DS-ALL. The predominant age group of DS-ALL patients is 3–10 years. Among them there was no T-cell ALL patient, and both favorable and unfavorable genetic abnormalities were significantly less common. There were no differences in early response between DS-ALL and non-DS-ALL patients. The event-free (61 ± 6%) and overall survival (74 ± 4%) of DS-ALL patients was significantly lower than in the comparison group (84 ± 3% and 89 ± 3% respectively; p < 0.001). No differences were found in relapse rate, while the treatment-related mortality (TRM) was higher in DS-ALL group (19.3 ± 3.5% versus 3.9 ± 1.2%; p˂0.001) in all treatment phase. The treatment results for DS-ALL patients remain unsatisfactory; therefore, new approaches to optimizing therapy are needed. High toxicity and associated TRM are the main problem. Future strategies to improve outcome in DS-ALL should include improved supportive care, the use of targeted drugs and immunotherapy, as well as the identification of new molecular genetic features." @default.
• W3156776836 created "2021-04-26" @default.
• W3156776836 creator A5006016810 @default.
• W3156776836 creator A5007787879 @default.
• W3156776836 creator A5008754173 @default.
• W3156776836 creator A5010698076 @default.
• W3156776836 creator A5011971433 @default.
• W3156776836 creator A5018161902 @default.
• W3156776836 creator A5021829571 @default.
• W3156776836 creator A5024874914 @default.
• W3156776836 creator A5032825631 @default.
• W3156776836 creator A5042925696 @default.
• W3156776836 creator A5050745178 @default.
• W3156776836 creator A5051965702 @default.
• W3156776836 creator A5056961943 @default.
• W3156776836 creator A5058046436 @default.
• W3156776836 creator A5061421398 @default.
• W3156776836 creator A5066722478 @default.
• W3156776836 creator A5069453886 @default.
• W3156776836 creator A5071481582 @default.
• W3156776836 creator A5071842464 @default.
• W3156776836 date "2021-04-21" @default.
• W3156776836 modified "2023-10-06" @default.
• W3156776836 title "Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience" @default.
• W3156776836 cites W1491743733 @default.
• W3156776836 cites W1777302976 @default.
• W3156776836 cites W1967262331 @default.
• W3156776836 cites W1982357299 @default.
• W3156776836 cites W2003599089 @default.
• W3156776836 cites W2014831634 @default.
• W3156776836 cites W2016830328 @default.
• W3156776836 cites W2021100796 @default.
• W3156776836 cites W2025782007 @default.
• W3156776836 cites W2045394616 @default.
• W3156776836 cites W2049292893 @default.
• W3156776836 cites W2052208292 @default.
• W3156776836 cites W2056345221 @default.
• W3156776836 cites W2069358335 @default.
• W3156776836 cites W2106545530 @default.
• W3156776836 cites W2120945789 @default.
• W3156776836 cites W2129910825 @default.
• W3156776836 cites W2139245238 @default.
• W3156776836 cites W2147941530 @default.
• W3156776836 cites W2153088153 @default.
• W3156776836 cites W2155183325 @default.
• W3156776836 cites W2163176957 @default.
• W3156776836 cites W2167789626 @default.
• W3156776836 cites W2803691501 @default.
• W3156776836 cites W2977606681 @default.
• W3156776836 cites W4293241248 @default.
• W3156776836 cites W84908148 @default.
• W3156776836 doi "https://doi.org/10.24287/1726-1708-2021-20-1-14-26" @default.
• W3156776836 hasPublicationYear "2021" @default.
• W3156776836 type Work @default.
• W3156776836 sameAs 3156776836 @default.
• W3156776836 citedByCount "1" @default.
• W3156776836 countsByYear W31567768362022 @default.
• W3156776836 crossrefType "journal-article" @default.
• W3156776836 hasAuthorship W3156776836A5006016810 @default.
• W3156776836 hasAuthorship W3156776836A5007787879 @default.
• W3156776836 hasAuthorship W3156776836A5008754173 @default.
• W3156776836 hasAuthorship W3156776836A5010698076 @default.
• W3156776836 hasAuthorship W3156776836A5011971433 @default.
• W3156776836 hasAuthorship W3156776836A5018161902 @default.
• W3156776836 hasAuthorship W3156776836A5021829571 @default.
• W3156776836 hasAuthorship W3156776836A5024874914 @default.
• W3156776836 hasAuthorship W3156776836A5032825631 @default.
• W3156776836 hasAuthorship W3156776836A5042925696 @default.
• W3156776836 hasAuthorship W3156776836A5050745178 @default.
• W3156776836 hasAuthorship W3156776836A5051965702 @default.
• W3156776836 hasAuthorship W3156776836A5056961943 @default.
• W3156776836 hasAuthorship W3156776836A5058046436 @default.
• W3156776836 hasAuthorship W3156776836A5061421398 @default.
• W3156776836 hasAuthorship W3156776836A5066722478 @default.
• W3156776836 hasAuthorship W3156776836A5069453886 @default.
• W3156776836 hasAuthorship W3156776836A5071481582 @default.
• W3156776836 hasAuthorship W3156776836A5071842464 @default.
• W3156776836 hasBestOaLocation W31567768361 @default.
• W3156776836 hasConcept C118552586 @default.
• W3156776836 hasConcept C121608353 @default.
• W3156776836 hasConcept C126322002 @default.
• W3156776836 hasConcept C187212893 @default.
• W3156776836 hasConcept C194409129 @default.
• W3156776836 hasConcept C2778461978 @default.
• W3156776836 hasConcept C2779954681 @default.
• W3156776836 hasConcept C2909143077 @default.
• W3156776836 hasConcept C2909962599 @default.
• W3156776836 hasConcept C71924100 @default.
• W3156776836 hasConceptScore W3156776836C118552586 @default.
• W3156776836 hasConceptScore W3156776836C121608353 @default.
• W3156776836 hasConceptScore W3156776836C126322002 @default.
• W3156776836 hasConceptScore W3156776836C187212893 @default.
• W3156776836 hasConceptScore W3156776836C194409129 @default.
• W3156776836 hasConceptScore W3156776836C2778461978 @default.
• W3156776836 hasConceptScore W3156776836C2779954681 @default.
• W3156776836 hasConceptScore W3156776836C2909143077 @default.
• W3156776836 hasConceptScore W3156776836C2909962599 @default.
• W3156776836 hasConceptScore W3156776836C71924100 @default.

• next